Dr. Gaskari leads an integrated clinical enterprise spanning pharmacy, clinical nutrition, laboratory services, and cell and gene therapy programs across inpatient, outpatient, specialty, infusion and home-based care. She led the development of an AI-driven total parenteral nutrition model that advanced precision dosing and improved neonatal outcomes, work published in Nature Medicine and recognized with a “Top 10 Clinical Research Achievement Award” from the Clinical Research Forum. Under her leadership, the organization earned the Utilization Review Accreditation Commission “Pioneer Award for Excellence” in patient management for two consecutive years, and her work in cell and gene therapy earned the Vizient “Innovation Visionary Award.” Dr. Gaskari was one of only seven chief pharmacy officers invited to the White House as part of the Cancer Moonshot initiative to address drug shortages, contributing to a first-of-its-kind drug resiliency and transparency pilot. As chair of the Children’s Hospital Association’s pharmacy executive steering committee, she led negotiation of a Vizient contract for 33 hospitals, delivering significant cost savings. She also launched a pharmacist-led infusion suite that expands pediatric access and generates new revenue, and she serves as a commissioner for the Health Plan of San Mateo.
